Abstract
We present a case of Candida dubliniensis meningitis that developed 2 months after apparently successful treatment of an episode of C. dubliniensis candidemia in a heart-lung transplant recipient in Australia. This case highlights the importance of follow-up in patients with candidemia or disseminated infection, especially in immunosuppressed patients.
MeSH terms
-
Antifungal Agents / therapeutic use
-
Candida / classification
-
Candida / isolation & purification*
-
Candidiasis / complications*
-
Candidiasis / drug therapy
-
Candidiasis / microbiology
-
Caspofungin
-
Echinocandins / therapeutic use
-
Fluconazole / therapeutic use
-
Fungemia / complications*
-
Fungemia / drug therapy*
-
Fungemia / microbiology
-
Heart Transplantation / adverse effects
-
Humans
-
Lipopeptides
-
Male
-
Meningitis, Fungal / microbiology*
-
Middle Aged
Substances
-
Antifungal Agents
-
Echinocandins
-
Lipopeptides
-
Fluconazole
-
Caspofungin